FDA Clearance Tracker · K201956
Zeus IFA ANA HEp-2 Test System, Zeus dIFine
Last checked: Nov 19, 2026Latest source record: Apr 29, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Apr 29, 2022
Substantially Equivalent
Time to decision
654 days
Received Jul 14, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K201956
- Device name
- Zeus IFA ANA HEp-2 Test System, Zeus dIFine
- Applicant
- Zeus Scientific, Inc.
- Applicant location
- Raritan, NJ
- Received
- Jul 14, 2020
- Decided
- Apr 29, 2022
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.5100
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DHN. The earliest in FDA's data is K760153, decided Jul 20, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201956
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Zeus Scientific, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K190907 · Decided Jul 29, 2019 · 112 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K191240 · Decided Jul 29, 2019 · 82 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K191398 · Decided Jul 29, 2019 · 66 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.